The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ziprasidone Market Research Report 2024
Synopsis
Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic that is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its immediate release intramuscular injection form is approved for acute agitation in people with schizophrenia.
The global Ziprasidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ziprasidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ziprasidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ziprasidone include Pfizer, Sandoz, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Apotex, Dr. Reddy's Laboratories, Wockhardt, Aurobindo and Macleods Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ziprasidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ziprasidone.
Report Scope
The Ziprasidone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ziprasidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ziprasidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sandoz
Lupin Pharmaceuticals
Mylan Pharmaceuticals
Apotex
Dr. Reddy's Laboratories
Wockhardt
Aurobindo
Macleods Pharmaceuticals
Zydus Pharmaceuticals
Segment by Type
Oral Capsule
Injection
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ziprasidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ziprasidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic that is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its immediate release intramuscular injection form is approved for acute agitation in people with schizophrenia.
The global Ziprasidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ziprasidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ziprasidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ziprasidone include Pfizer, Sandoz, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Apotex, Dr. Reddy's Laboratories, Wockhardt, Aurobindo and Macleods Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ziprasidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ziprasidone.
Report Scope
The Ziprasidone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ziprasidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ziprasidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sandoz
Lupin Pharmaceuticals
Mylan Pharmaceuticals
Apotex
Dr. Reddy's Laboratories
Wockhardt
Aurobindo
Macleods Pharmaceuticals
Zydus Pharmaceuticals
Segment by Type
Oral Capsule
Injection
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ziprasidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ziprasidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ziprasidone Market Overview
1.1 Product Overview and Scope of Ziprasidone
1.2 Ziprasidone Segment by Type
1.2.1 Global Ziprasidone Market Value Comparison by Type (2024-2030)
1.2.2 Oral Capsule
1.2.3 Injection
1.3 Ziprasidone Segment by Application
1.3.1 Global Ziprasidone Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Ziprasidone Market Size Estimates and Forecasts
1.4.1 Global Ziprasidone Revenue 2019-2030
1.4.2 Global Ziprasidone Sales 2019-2030
1.4.3 Global Ziprasidone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ziprasidone Market Competition by Manufacturers
2.1 Global Ziprasidone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ziprasidone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ziprasidone Average Price by Manufacturers (2019-2024)
2.4 Global Ziprasidone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ziprasidone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ziprasidone, Product Type & Application
2.7 Ziprasidone Market Competitive Situation and Trends
2.7.1 Ziprasidone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ziprasidone Players Market Share by Revenue
2.7.3 Global Ziprasidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ziprasidone Retrospective Market Scenario by Region
3.1 Global Ziprasidone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ziprasidone Global Ziprasidone Sales by Region: 2019-2030
3.2.1 Global Ziprasidone Sales by Region: 2019-2024
3.2.2 Global Ziprasidone Sales by Region: 2025-2030
3.3 Global Ziprasidone Global Ziprasidone Revenue by Region: 2019-2030
3.3.1 Global Ziprasidone Revenue by Region: 2019-2024
3.3.2 Global Ziprasidone Revenue by Region: 2025-2030
3.4 North America Ziprasidone Market Facts & Figures by Country
3.4.1 North America Ziprasidone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ziprasidone Sales by Country (2019-2030)
3.4.3 North America Ziprasidone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ziprasidone Market Facts & Figures by Country
3.5.1 Europe Ziprasidone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ziprasidone Sales by Country (2019-2030)
3.5.3 Europe Ziprasidone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ziprasidone Market Facts & Figures by Country
3.6.1 Asia Pacific Ziprasidone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ziprasidone Sales by Country (2019-2030)
3.6.3 Asia Pacific Ziprasidone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ziprasidone Market Facts & Figures by Country
3.7.1 Latin America Ziprasidone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ziprasidone Sales by Country (2019-2030)
3.7.3 Latin America Ziprasidone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ziprasidone Market Facts & Figures by Country
3.8.1 Middle East and Africa Ziprasidone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ziprasidone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ziprasidone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ziprasidone Sales by Type (2019-2030)
4.1.1 Global Ziprasidone Sales by Type (2019-2024)
4.1.2 Global Ziprasidone Sales by Type (2025-2030)
4.1.3 Global Ziprasidone Sales Market Share by Type (2019-2030)
4.2 Global Ziprasidone Revenue by Type (2019-2030)
4.2.1 Global Ziprasidone Revenue by Type (2019-2024)
4.2.2 Global Ziprasidone Revenue by Type (2025-2030)
4.2.3 Global Ziprasidone Revenue Market Share by Type (2019-2030)
4.3 Global Ziprasidone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ziprasidone Sales by Application (2019-2030)
5.1.1 Global Ziprasidone Sales by Application (2019-2024)
5.1.2 Global Ziprasidone Sales by Application (2025-2030)
5.1.3 Global Ziprasidone Sales Market Share by Application (2019-2030)
5.2 Global Ziprasidone Revenue by Application (2019-2030)
5.2.1 Global Ziprasidone Revenue by Application (2019-2024)
5.2.2 Global Ziprasidone Revenue by Application (2025-2030)
5.2.3 Global Ziprasidone Revenue Market Share by Application (2019-2030)
5.3 Global Ziprasidone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Ziprasidone Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Corporation Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sandoz Ziprasidone Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Lupin Pharmaceuticals
6.3.1 Lupin Pharmaceuticals Corporation Information
6.3.2 Lupin Pharmaceuticals Description and Business Overview
6.3.3 Lupin Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lupin Pharmaceuticals Ziprasidone Product Portfolio
6.3.5 Lupin Pharmaceuticals Recent Developments/Updates
6.4 Mylan Pharmaceuticals
6.4.1 Mylan Pharmaceuticals Corporation Information
6.4.2 Mylan Pharmaceuticals Description and Business Overview
6.4.3 Mylan Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Pharmaceuticals Ziprasidone Product Portfolio
6.4.5 Mylan Pharmaceuticals Recent Developments/Updates
6.5 Apotex
6.5.1 Apotex Corporation Information
6.5.2 Apotex Description and Business Overview
6.5.3 Apotex Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Apotex Ziprasidone Product Portfolio
6.5.5 Apotex Recent Developments/Updates
6.6 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Corporation Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dr. Reddy's Laboratories Ziprasidone Product Portfolio
6.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.7 Wockhardt
6.6.1 Wockhardt Corporation Information
6.6.2 Wockhardt Description and Business Overview
6.6.3 Wockhardt Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wockhardt Ziprasidone Product Portfolio
6.7.5 Wockhardt Recent Developments/Updates
6.8 Aurobindo
6.8.1 Aurobindo Corporation Information
6.8.2 Aurobindo Description and Business Overview
6.8.3 Aurobindo Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aurobindo Ziprasidone Product Portfolio
6.8.5 Aurobindo Recent Developments/Updates
6.9 Macleods Pharmaceuticals
6.9.1 Macleods Pharmaceuticals Corporation Information
6.9.2 Macleods Pharmaceuticals Description and Business Overview
6.9.3 Macleods Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Macleods Pharmaceuticals Ziprasidone Product Portfolio
6.9.5 Macleods Pharmaceuticals Recent Developments/Updates
6.10 Zydus Pharmaceuticals
6.10.1 Zydus Pharmaceuticals Corporation Information
6.10.2 Zydus Pharmaceuticals Description and Business Overview
6.10.3 Zydus Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zydus Pharmaceuticals Ziprasidone Product Portfolio
6.10.5 Zydus Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ziprasidone Industry Chain Analysis
7.2 Ziprasidone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ziprasidone Production Mode & Process
7.4 Ziprasidone Sales and Marketing
7.4.1 Ziprasidone Sales Channels
7.4.2 Ziprasidone Distributors
7.5 Ziprasidone Customers
8 Ziprasidone Market Dynamics
8.1 Ziprasidone Industry Trends
8.2 Ziprasidone Market Drivers
8.3 Ziprasidone Market Challenges
8.4 Ziprasidone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
